today announced that it has filed a patent infringement lawsuit against W.L. Gore & Associates . AGA Medical is usually alleging that Gore is usually infringing AGA Medical’s U.S. Patent No. 5,994,738 which covers particular transcatheter occlusion products for the treating structural heart defects. AGA Medical is definitely looking for damages against Gore and a permanent injunction prohibiting them from manufacturing and selling the Gore HELEX Septal Occluder both in america and overseas. We’ve invested extensively to develop these new technologies in fact it is essential for us to protect these investments by protecting our intellectual property. We have invested extensively to build up these new technologies in fact it is essential for us to safeguard these investments by protecting our intellectual house.Given the effects from the GACRS cohort, we performed all subsequent analyses under a dominant genetic model. P ideals for all testing in the replication cohorts were one-sided, since all associations in these cohorts were in the same path as those in the GACRS cohort. Mixed P values for all cohorts were calculated by using both Fisher’s method and a weighted z-score method to account for differences in sample size among the analysis cohorts.20 We estimated the populace risk of COPD due to MMP12 genotypes and the discriminatory power of the genotypes to predict COPD onset in the NAS cohort.21 Results Cohorts Baseline characteristics of the kids in the GACRS, CAMP, and BAMSE cohorts and of the adults in the eoCOPD, NETT, Lovelace, and NAS cohorts are shown in Table 1Table 1Baseline Features of the Subjects in the analysis Cohorts.